In the retrospective cohort, 15 patients (17%) had MSI resulting from MMR protein deficiency, 28 patients (33%) had alterations in p53 revealing a CIN profile and 3 patients (3%) expressed EBER antigen and have been classified as EBV-positive. This evidence concerns the gene TP53 and hereditary thrombophilia due to congenital protein S deficiency.